Literature DB >> 10861027

Cutting edge: antilisterial activity of CD8+ T cells derived from TNF-deficient and TNF/perforin double-deficient mice.

D W White1, V P Badovinac, G Kollias, J T Harty.   

Abstract

The mechanisms by which CD8+ T cells mediate immunity against bacterial pathogens remain largely unknown. Perforin-dependent cytolysis plays a role, but is not required for CD8+ T cell-mediated immunity against Listeria monocytogenes. TNF is essential for CD8+ T cell immunity to L. monocytogenes, but the cellular source of TNF is undefined. TNF-deficient and TNF/perforin double-deficient mice were used to generate CD8+ T cells specific for an L. monocytogenes-derived Ag. Wild-type and TNF-deficient CD8+ T cells mediated antilisterial immunity in wild-type but not TNF-deficient host mice, revealing that CD8+ T cell-derived TNF is not required for CD8+ T cell-mediated antilisterial immunity, but demonstrating a role for TNF derived from other cell types. TNF/perforin double-deficient CD8+ T cells mediated antilisterial immunity in the liver, but not in the spleen, of wild-type recipient mice, suggesting that perforin-independent immunity in the spleen requires CD8+ T cell-derived TNF.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861027     DOI: 10.4049/jimmunol.165.1.5

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Detection and analysis of antigen-specific CD8+ T cells.

Authors:  V P Badovinac; J T Harty
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Safety and immunogenicity in neonatal mice of a hyperattenuated Listeria vaccine directed against human immunodeficiency virus.

Authors:  Marina Rayevskaya; Natasha Kushnir; Fred R Frankel
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection.

Authors:  D R Roach; H Briscoe; B M Saunders; W J Britton
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  Listeria monocytogenes: a model pathogen to study antigen-specific memory CD8 T cell responses.

Authors:  Shaniya H Khan; Vladimir P Badovinac
Journal:  Semin Immunopathol       Date:  2015-04-10       Impact factor: 9.623

5.  Interleukin-1 receptor type 1 is essential for control of cerebral but not systemic listeriosis.

Authors:  Martina Deckert; Simona Virna; Monika Sakowicz-Burkiewicz; Sonja Lütjen; Sabine Soltek; Horst Bluethmann; Dirk Schlüter
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

6.  Membrane tumor necrosis factor confers partial protection to Listeria infection.

Authors:  David Torres; Laure Janot; Valerie F J Quesniaux; Sergei I Grivennikov; Isabelle Maillet; Jonathon D Sedgwick; Bernhard Ryffel; Francois Erard
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

7.  Effect of 6-hydroxydopamine on host resistance against Listeria monocytogenes infection.

Authors:  T Miura; T Kudo; A Matsuki; K Sekikawa; Y Tagawa; Y Iwakura; A Nakane
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 8.  Mechanisms of Memory T Cell Activation and Effective Immunity.

Authors:  Grégoire Lauvau; Saïdi M'Homa Soudja
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

9.  Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection.

Authors:  Nahed Ismail; Heather L Stevenson; David H Walker
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

10.  Perinatal Listeria monocytogenes susceptibility despite preconceptual priming and maintenance of pathogen-specific CD8(+) T cells during pregnancy.

Authors:  Dayna R Clark; Vandana Chaturvedi; Jeremy M Kinder; Tony T Jiang; Lijun Xin; James M Ertelt; Sing Sing Way
Journal:  Cell Mol Immunol       Date:  2014-09-22       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.